|
Dey helps people breathe easier. The company, a subsidiary of generic drugmaker Mylan, makes prescription drugs for the treatment of allergies and respiratory diseases. Dey markets EpiPen autoinjectors, used by patients to self-administer epinephrine for severe allergic reactions. Its premeasured unit-dose inhalation products include treatments for asthma and chronic obstructive pulmonary disease (COPD). These treatments, called bronchodialators, are used in air-driven breathing devices called nebulizers and include branded DuoNeb and Perforomist products. It also offers several non-branded generic nebulizer treatments. A direct sales force markets Dey's products to doctors, pharmacies, and wholesalers.
|
| | | Contact Information | |
Address: |
2751 Napa Valley Corporate Dr.
Napa, CA 94558
| | Phone: | 707-224-3200 | | Fax: | 707-224-9264 |
|
| Financial
Highlights | | Fiscal Year End: | December |
|
|
Key People
| | • |
President:
Carolyn Myers
| | • |
SVP Operations:
Gary L. Michaud
| | • |
SVP and CFO:
Pamela R. Marrs
|
|
|
